Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANFLUTE: Benzylpenicillin vs. Flucloxacillin for PSSA Bloodstream Infections
NCT03632642Phase 4Withdrawn
- Sponsor
- The University of Queensland
- Start
- Jul 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of benzylpenicillin in Staphylococcus aureus infection, sponsored by The University of Queensland. Primary endpoint: Desirability of Outcome Ranking at 90 days. Planned start Jul 2019; status: withdrawn.
02
Drugs
benzylpenicillin
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT03632642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03632642.